Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
17. Juni 2019 11:05 ET
|
I-MED Pharma
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal...
I-MED Pharma Celebrates 30 Years of Providing OSD & Surgical Solutions to the Global Eye Care Community
01. April 2019 10:22 ET
|
I-MED Pharma
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary providing OSD &...
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
26. März 2019 13:42 ET
|
I-MED Pharma
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with...
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands
02. Oktober 2018 10:54 ET
|
I-MED Pharma
MONTREAL, Oct. 02, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina
03. April 2018 14:30 ET
|
I-MED Pharma
MONTREAL, April 03, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian Company specializing in dry eye diagnosis and management, is pleased to announce receiving regulatory approval from INVIMA...
I-MED Pharma's I-PEN® Does Not Infringe the TearLab Patent
20. Februar 2018 15:44 ET
|
I-MED Pharma
MONTREAL, Feb. 20, 2018 (GLOBE NEWSWIRE) -- On February 14th TearLab issued a press release indicating it will appeal after its defeat in a patent infringement action against I-MED Pharma Inc. in...
I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.
08. Januar 2018 13:02 ET
|
I-MED Pharma
MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...